Harvard University

University / College


Location: Cambridge, MA, United States (USA) (US) US

ISNI: 000000041936754X

ROR: https://ror.org/03vek6s52

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Other Causes of Limbal Stem Cell Deficiency Reply (2019) Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, et al. Journal article, Letter Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu (2019) Anand S, Caplin B, Gonzalez-Quiroz M, Schensul SL, Bhalla V, Parada X, Nanayakkara N, et al. Journal article, Editorial Neutrophils promote venular thrombosis by shaping the rheological environment for platelet aggregation (2019) Puhr-Westerheide D, Schink SJ, Fabritius M, Mittmann L, Hessenauer ME, Pircher J, Zuchtriegel G, et al. Journal article Characterization of the Native Passive Film on Ferrite and Austenite Phases of Sensitized 2205 Duplex Stainless Steel (2019) Rahimi E, Rafsanjani-Abbasi A, Davoodi A, Hosseinpour S Journal article Machine learning in cardiovascular magnetic resonance: Basic concepts and applications (2019) Leiner T, Rueckert D, Suinesiaputra A, Baessler B, Nezafat R, Isgum I, Young AA Journal article, Review article Brain connectivity measures improve modeling of functional outcome after acute ischemic stroke (2019) Ktena SI, Schirmer MD, Etherton MR, Giese AK, Tuozzo C, Mills BB, Rueckert D, et al. Journal article Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial (2019) Stone J, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Long-Term Outcome of Tocilizumab for Patients with Giant Cell Arteritis: Results from Part 2 of a Randomized Controlled Phase 3 Trial (2019) Stone J, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Maintained Benefit in Health-Related Quality of Life of Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Results from the Open-Label, Long-Term Extension of a Phase 3 Randomized Controlled Trial (2019) Stone J, Han J, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution SIXTE: a generic X-ray instrument simulation toolkit (2019) Dauser T, Falkner S, Lorenz M, Kirsch C, Peille P, Cucchetti E, Schmid C, et al. Journal article